These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10907114)

  • 1. Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes.
    Gervaise N; Garrigue MA; Lasfargues G; Lecomte P
    Diabetologia; 2000 Jun; 43(6):703-8. PubMed ID: 10907114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors.
    Pérez-Castrillón JL; De Luis D; Martín-Escudero JC; Asensio T; del Amo R; Izaola O
    J Diabetes Complications; 2004; 18(6):317-21. PubMed ID: 15531180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for lower extremity arterial disease in non-insulin-dependent diabetic persons.
    Katsilambros NL; Tsapogas PC; Arvanitis MP; Tritos NA; Alexiou ZP; Rigas KL
    Diabet Med; 1996 Mar; 13(3):243-6. PubMed ID: 8689845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism.
    Starck M; Schiele F; Herbeth B; Vincent-Viry M; Beaud B; Siest G; Visvikis S
    Atherosclerosis; 2001 Apr; 155(2):509-16. PubMed ID: 11254923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of apolipoproteins C3 and E with metabolic changes in HIV-infected adults treated with a protease-inhibitor-containing antiretroviral therapy.
    Bard JM; Lassalle R; Capeau J; Bach-Ngohou K; Nazih-Sanderson F; Rémy G; Reynes J; Ecobichon JL; Savès M; Raffi F;
    Antivir Ther; 2006; 11(3):361-70. PubMed ID: 16759053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gender differences and diabetic status in the relationship of blood apolipoprotein C-III, free fatty acids and triglycerides in subjects at risk for glucose intolerance].
    Flórez H; Méndez AJ; Jones L; Goldberg RB
    Invest Clin; 1999 Mar; 40(1):51-66. PubMed ID: 10198561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of lipids, apoproteins and lipoproteins in patients with coronary disease and in a control population].
    Marzullo C; Michotey O; Bourderont D; Levy J; Jung S; Tissot J; Huber-Braun C; Dorr R
    Ann Biol Clin (Paris); 1994; 52(10):717-20. PubMed ID: 7747879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of lipids to coronary heart disease in diabetes mellitus.
    Stewart MW; Laker MF; Alberti KG
    J Intern Med Suppl; 1994; 736():41-6. PubMed ID: 7986307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
    Lee SJ; Campos H; Moye LA; Sacks FM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):853-8. PubMed ID: 12637336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. Etude Cas Témoins sur 'Infarctus du Myocarde.
    Luc G; Fievet C; Arveiler D; Evans AE; Bard JM; Cambien F; Fruchart JC; Ducimetiere P
    J Lipid Res; 1996 Mar; 37(3):508-17. PubMed ID: 8728314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum lipids and apolipoproteins AI, B100, CI and CII in noninsulin-dependent diabetics].
    Liu BW; Liang JS; Fu MD
    Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):627-9, 653-4. PubMed ID: 3147855
    [No Abstract]   [Full Text] [Related]  

  • 13. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.
    Uusitupa MI; Niskanen LK; Siitonen O; Voutilainen E; Pyörälä K
    Diabetologia; 1993 Nov; 36(11):1175-84. PubMed ID: 8270133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrovascular complications and their associated risk factors in type 2 diabetic patients in Sana'a city, Yemen.
    Al-Khawlani A; Atef ZA; Al-Ansi A
    East Mediterr Health J; 2010 Aug; 16(8):851-8. PubMed ID: 21469567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study.
    Roselli della Rovere G; Lapolla A; Sartore G; Rossetti C; Zambon S; Minicuci N; Crepaldi G; Fedele D; Manzato E
    Nutr Metab Cardiovasc Dis; 2003 Feb; 13(1):46-51. PubMed ID: 12772437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal composition of apoproteins C-I, C-II, and C-III in plasma and very-low-density lipoproteins of non-insulin-dependent diabetic Chinese.
    Pan XR; Cheung MC; Walden CE; Hu SX; Bierman EL; Albers JJ
    Clin Chem; 1986 Oct; 32(10):1914-20. PubMed ID: 3757210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of risk factors of macrovascular complications. Peripheral vascular disease, cerebral vascular disease, and coronary heart disease in Japanese type 2 diabetes mellitus patients.
    Asakawa H; Tokunaga K; Kawakami F
    J Diabetes Complications; 2000; 14(6):307-13. PubMed ID: 11120454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
    Jiang R; Schulze MB; Li T; Rifai N; Stampfer MJ; Rimm EB; Hu FB
    Diabetes Care; 2004 Aug; 27(8):1991-7. PubMed ID: 15277429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol rich apo B containing lipoproteins and smoking are independently associated with macrovascular disease in normotensive NIDDM patients.
    Dean JD; Matthews SB; Dolben J; Carolan G; Luzio S; Owens DR
    Diabet Med; 1994 Oct; 11(8):740-7. PubMed ID: 7851067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.